Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Transglutaminase does not modify human hair.

A mutation in the EDNRA gene causes Oro-Oto-Cardiac syndrome, affecting face and heart development.

Certain genetic variations can make people more likely to experience hair loss and low white blood cell count from azathioprine.

Inhibiting connective tissue sheath contraction may improve hair growth in male pattern baldness.

Endoglin is crucial for proper hair growth cycles and stem cell activation in mice.

Mutations in the Vitamin D receptor gene can cause hair loss similar to mutations in the Hairless gene.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Genetic factors could lead to personalized treatments for hair loss.

Scientists restored fertility in male mice lacking a key fertility gene by using a modified gene.

KRT72 gene helps form hair.

AI-09 is safe, effective, and reduces wrinkles for up to 6 months.

Steroids may not work well for alopecia areata because of high unoccupied receptors and low thioredoxin levels.

UBC13 and UBC22 enzymes are important for plant growth and development in Arabidopsis thaliana.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

lncRNA MTC helps goat skin cells grow and may aid hair growth by controlling proteins linked to cell growth.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

The SNP rs6457452 is linked to a higher risk of alopecia areata in Koreans.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

A specific gene change in APCDD1 increases the risk of hair loss.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Men with androgenetic alopecia have lower levels of certain proteins and more cell damage.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

ASLNC168501 may help restore hair growth in androgenetic alopecia by improving hair follicle stem cell function.